![]() |
Medical Policy | ||
| Subject: Adjustable Band for the Treatment of Non-Synostotic Plagiocephaly and Brachycephaly, Infants | |||
| Policy #: OR-PR.00002 | Current Effective Date: | 02/05/2007 | |
| Status: Revised | Last Review Date: | 12/07/2006 | |
|
Description/Scope
This policy addresses the use of the adjustable band as a non-invasive treatment for non-synostotic plagiocephaly (asymmetrically shaped head) and brachycephaly (abnormally shaped head; shortened in antero-posterior dimension without asymmetry) in infants. The adjustable band involves the use of a custom-molded orthotic, either a helmet or a band that can progressively mold the shape of the cranium. Treatment is typically initiated around 5-6 months of age and continues for an average of 4 to 5 months.
Policy Statement
Not Medically Necessary:
Reconstructive:
The custom molded orthotic is designed to fit a child’s head from 2-4 months. A second helmet or band may be required if the asymmetry has not resolved or significantly improved after 2-4 months.
Investigational/Not Medically Necessary:
The adjustable band is considered investigational/not medically necessary as a treatment of brachycephaly. Rationale
Multiple case series have demonstrated that the adjustable band can reshape non-synostotic plageocephalic cranial asymmetries. These asymmetries may involve the cranial base, the cranial vault and the orbitotragial distance.
The evaluation of the medical necessity of the adjustable band for cranial asymmetries requires data that support 1) that nonsynostotic plagiocephaly is associated with a functional impairment; and 2) that dynamic orthotic plagiocephaly results in an improvement in the functional impairment. Potential functional impairments include learning disabilities, ocular dysfunction and jaw malocclusion. To date, there is inadequate data to support that plagiocephaly results in functional impairments. For example, Miller and colleagues (2000) examined the long-term development outcomes in patients with deformational plagiocephaly in a case series of 181 children with positional plagiocephaly; families were invited to participate in a telephone interview regarding developmental outcomes. A total of 63 of the 181 contacted families agreed to participate in the interview; 39.7% of the children had received special help in primary school. Given the approximate 33% participation rate in this survey, no conclusions can be drawn. In addition, 27 of the 63 respondents had used helmet therapy as part of the treatment. Gupta and colleagues (2003) reported on the ophthalmologic findings in 93 patients with deformational plagiocephaly; 24% had unilateral or bilateral astigmatism compared with 19% prevalence in the normal population. This study did not indicate whether the participants did or did not undergo helmet therapy. Balan and colleagues (2002) examined auditory event-related potentials in 10 infants with deformational plagiocephaly compared to 15 sex- and age-matched controls. The infants with plagiocephaly exhibited smaller amplitudes in response. Again, this study did not indicate whether the participants had used helmet therapy. In summary, no controlled trials have documented functional impairments in infants with plagiocephaly and whether or not these impairments are improved with helmet therapy. Therefore, the treatment of nonsynostotic plagiocephaly using the adjustable band is considered not medically necessary. Brachycephaly described a head shape, that although symmetrical, is considered abnormal.
Nevertheless, the adjustable band may be considered eligible for coverage under reconstructive benefits, based on available data that the therapy can indeed reshape the cranium to a more normal contour. If the adjustable band is considered eligible for coverage under the reconstructive benefit, the following issues are relevant.
Studies of helmet therapy typically describe 3 different types of asymmetry; asymmetry of the cranial base, cranial vault, and orbitotragial distance. All 3 result in visible facial asymmetry. The degree of asymmetry that would warrant correction is not well addressed in the published medical literature. However, one can examine the degree of asymmetry reported in case series of patients undergoing adjustable banding. The following table presents the mean pretreatment asymmetries reported in large case series.
* In this report, the asymmetry was measured from the tragus to the frontozygomatic point instead of the excanthion
The study by Moss and colleagues (1997) was the only article that attempted to distinguish degrees of asymmetry. Mild to moderate asymmetry was defined as 12 mm or less, while moderate to severe asymmetry was defined as greater than 12 mm. Treatment with a helmet therapy was offered to those with moderate to severe asymmetry, while the rest were treated with repositioning therapy.
Brachycephaly describes a head, that although symmetric, which is abnormally shaped (flattened), and is assessed using the cephalic index (CI). Medical dictionaries and anthropologic sources define brachycephaly as a cranial index (width divided by length x 100%) greater than 81%. A literature search did not identify randomized prospective comparative clinical trials which establish the efficacy of cranial remodeling bands and helmets as a treatment of brachycephaly.
In a retrospective chart-review study, Teichgraeber et al (2004) evaluated treatment outcomes in groups of children with positional brachycephaly and plagiocephaly and concluded that the use of a cranial orthotic device was effective for both groups, but that more children in the plagiocephaly group were normalized after treatment. In this study infants were treated with either repositioning (n=132) or with the DOC™ band (n=292). Of the 292 treated with a molding orthotic, 64 were brachycephalic and 228 had plagiocephaly. Of 64 patients with brachycephaly treated with banding, 33 met specific inclusion criteria: charted diagnosis of brachycephaly, age 12 months or less, and complete anthropomorphic measurements recorded in the record. In the brachycephalic group, significant improvement occurred in the CI (P<0.01) after treatment with the DOC™ band but infants were described as still significantly different from age and sex adjusted norms. Only one child in this group normalized to within 1 SD of the norm by the end of treatment. In this study, cranial orthotic treatment was reported as more effective in treating posterior plagiocephaly than brachycephaly, but specific data with benchmark norms were not provided. The limitations of this study included its retrospective design and the lack of reporting of comparative data from the group treated with positioning alone.
A more recent study by Graham et al (2005) compared the effect of repositioning versus helmet therapy on CI in infants referred for brachycephaly. This study collected longitudinal data on 193 infants referred and treated for abnormal head shapes at a single institution between 1997 and 2001. The CI was compared before and after treatment with either repositioning or helmet therapy. In a subgroup of infants (n= 92) with severe brachycephaly (CI ≥ 90%), the authors concluded that although both groups (repositioning and orthotic) improved, repositioning was less effective than cranial orthotic therapy based on reduction in CI (2.5% vs 5.3%). The limitations of this study include a lack of randomized design, baseline differences in initial mean age and cephalic index, and differences in mean duration of therapy between the two treatment groups.
Background/Overview
Plagiocephaly, which refers to an asymmetrically shaped head, can be subdivided into synostotic and non-synostotic types. Synostotic plagiocephaly describes an asymmetrically shaped head due to premature closure of the sutures of the cranium. In plagiocephaly without synostosis, the sutures remain open. Plagiocephaly without synostosis, also called positional or deformational plagiocephaly, can be secondary to various environmental factors including, but not limited to, premature birth, restrictive intrauterine environment, birth trauma, torticollis, cervical anomalies, and sleeping position. Brachycephaly refers to a head shape that is not asymmetric but is disproportionately short. The incidence of plagiocephaly and brachycephaly has increased rapidly in recent years as a result of the “Back to Sleep” campaign initiated in 1992 by the American Academy of Pediatrics (AAP), in which a supine sleeping position is recommended to reduce the risk of sudden infant death syndrome (SIDS). It is estimated that one of every 60 neonates may have some degree of plagiocephaly or brachycephaly. Positional plagiocephaly typically consists of right or left occipital flattening with advancement of the ipsilateral ear and prominence of the ipsilateral frontal region, resulting in visible facial asymmetry. Occipital flattening may be self-perpetuating, in that once it occurs it may be increasingly difficult for the infant to turn and sleep on the other side. Assessment of plagiocephaly and brachycephaly are based on anthropomorphic measures of the head, using anatomical and bony landmarks.
There are 3 basic options for treating plagiocephaly and brachycephaly; no therapy, repositioning therapy, and adjustable band. Repositioning therapy includes supervised “tummy time,” or placement of the child in a half supine position with a towel or blanket roll behind the shoulder to position the occiput away from the flat side. Physical therapy may also be recommended, particularly if there is shortening or tightening of the sternocleidomastoid muscle. The adjustable band involves use of a custom-molded orthotic, either a helmet or band that can progressively mold the shape of the cranium by applying corrective forces to the frontal and occipital prominences while leaving room for growth in the adjacent flattened areas. Treatment is typically initiated around 5 to 6 months of age, frequently after a prior trial of repositioning therapy, and continues for an average of 4 to 5 months. Both helmets and cranial bands are recommended for wear 23 hours per day, with 1 hour off for skin care and hygiene.
Definitions
Brachycephaly describes a head shape that is symmetric and disproportionately wide, (width ÷ length x 100%) ≥ 81%.
Cranial base: Asymmetry of the cranial base is measured from the subnasal point (midline under the nose) to the tragus (the cartilaginous projection in front of the external auditory canal).
Orbitotragial depth: Asymmetry of the orbitotragial depth is measured from the exocanthion (outer corner of the eye fissure where the eyelids meet) to the tragus (the cartilaginous projection in front of the external auditory canal).
Plagiocephaly: a condition characterized by an abnormal head shape
Coding
The following codes for treatments and procedures applicable to this policy are included below for informational purposes. Inclusion or exclusion of a procedure, diagnosis or device code(s) does not constitute or imply member coverage or provider reimbursement policy. Please refer to the member's contract benefits in effect at the time of service to determine coverage or non-coverage of these services as it applies to an individual member.
Services are Not Medically Necessary:
HCPCS
ICD-9 Diagnosis
Services may be Reconstructive, when criteria are met: For the procedure and diagnosis codes listed above, services may be considered Reconstructive when criteria are met
Services are Investigational/Not Medically Necessary: For the procedure codes listed above, for the following diagnosis code when specified as brachycephaly, or when the code describes a procedure indicated in the Policy section as investigational/not medically necessary.
ICD-9 Diagnosis
References
Government Agency, Medical Society, and Other Authoritative Publications:
Web Sites for Additional Information
Index
Ballert Cranial Molding Helmet™ The use of specific product names is illustrative only. It is not intended to be a recommendation of one product over another, and is not intended to represent a complete listing of all products available. Policy History
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Federal and State law, as well as contract language, including definitions and specific contract provisions/exclusions, take precedence over Medical Policy and must be considered first in determining eligibility for coverage. The member's contract benefits in effect on the date that services are rendered must be used. Medical Policy, which addresses medical efficacy, should be considered before utilizing medical opinion in adjudication. Medical technology is constantly evolving, and we reserve the right to review and update Medical Policy periodically. No part of this publication may be reproduced, stored in a retrieval system or transmitted, in any form or by any means, electronic, mechanical, photocopying, or otherwise, without permission from the health plan. ©CPT Only - American Medical Association |